← Evidence map

ReviewExpert opinion on therapeutic targets2015

Bombesin receptor subtype 3 as a potential target for obesity and diabetes.

Nieves González et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

19 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 26066663